Home » Authors » Don Long

Articles by Don Long

Piper Jaffray Health Care Conference: Boston Sci tackles challenge of product growth, execution

Jan. 26, 2005

ViaCell Prices At Low End, But Gets $52.5M In 2005's First IPO

Jan. 24, 2005

ViaCell Prices At Low End, But Gets $52.5M In 2005's First IPO

Jan. 24, 2005

SurModics acquires remaining portion of InnoRx for $4.1M

Jan. 20, 2005

International Symposium on Endovascular Therapy: Belgian researchers present 'absorbable' metal stent data

Jan. 20, 2005

JAMA report seen supporting market uptake for Cypher DES

Jan. 13, 2005

New LSA 'angels' firm will offer device and biotech support

Jan. 7, 2005

Chlorhexidine gluconate key aid in battle vs. catheter infections

Jan. 4, 2005

Demographics drive health help in plastic surgery, cardio arenas

Jan. 4, 2005

Angioplasty/stenting, keyhole bypass are combined in a 'first'

Jan. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...